BB BIOTECH AG 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-10 11:12 am Sale |
2025-03-04 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 9,694,064 4.900% |
-250,000 (-2.51%) |
Filing |
| 2025-02-14 2:37 pm Purchase |
2024-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 9,944,064 5.000% |
750,000 (+8.16%) |
Filing |
| 2024-01-24 3:46 pm Purchase |
2024-01-19 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 9,194,064 5.100% |
5,000,000 (+119.22%) |
Filing |
| 2024-01-24 3:21 pm Unchanged |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 4,194,064 3.700% |
0 (Unchanged) |
Filing |
| 2023-02-14 4:18 pm Sale |
2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 4,194,064 5.700% |
-283,900 (-6.34%) |
Filing |
| 2022-02-11 4:39 pm Unchanged |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 4,477,964 7.100% |
0 (Unchanged) |
Filing |
| 2021-05-28 5:00 pm Purchase |
2021-05-19 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 4,477,964 15.900% |
530,000 (+13.42%) |
Filing |
| 2021-05-27 4:33 pm Purchase |
2021-05-19 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 4,477,964 15.900% |
1,085,000 (+31.98%) |
Filing |
| 2021-02-12 4:58 pm Purchase |
2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 3,947,964 14.200% |
220,000 (+5.90%) |
Filing |